About Iparomlimab/Tuvonralimab A mixture of the two engineered monoclonal antibodies iparomlimab, which is an immunoglobulin G4…
Socazolimab is a fully human anti-PD-L1 (programmed cell death 1 ligand 1) monoclonal antibody, an immune checkpoint…
Enlonstobart, a recombinant, fully humanised immunoglobulin G4 monoclonal antibody targeted against programmed cell death protein 1 (PD-1),…
Cadonilimab is a bispecific antibody that targets the PD-1 and CTLA-4 receptors on tumor cells to…